{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:53:40Z","timestamp":1773150820791,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.taap.2011.04.019","type":"journal-article","created":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T15:50:56Z","timestamp":1304783456000},"page":"267-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats"],"prefix":"10.1016","volume":"254","author":[{"given":"Mirja","family":"Nurmio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henna","family":"Joki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma A.","family":"M\u00e4\u00e4tt\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Kalervo","family":"V\u00e4\u00e4n\u00e4nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsi","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiina","family":"Laitala-Leinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2011.04.019_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00774-006-0684-1","article-title":"Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)","volume":"24","author":"Ando","year":"2006","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.taap.2011.04.019_bb0010","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa051140","article-title":"Altered bone and mineral metabolism in patients receiving imatinib mesylate","volume":"354","author":"Berman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2011.04.019_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00467-009-1249-z","article-title":"Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents","volume":"25","author":"Bianchi","year":"2010","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.taap.2011.04.019_bb0015","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1073\/pnas.88.11.4671","article-title":"Steel\u2013Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains","volume":"88","author":"Brannan","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.taap.2011.04.019_bb0020","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood-2004-10-3967","article-title":"Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib","volume":"105","author":"Dewar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.taap.2011.04.019_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2006.09.007","article-title":"Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity","volume":"551","author":"El Hajj Dib","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2011.04.019_bb0030","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jcb.20219","article-title":"To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF","volume":"93","author":"Fiedler","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.taap.2011.04.019_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2184.2007.00438.x","article-title":"Inhibition of platelet-derived growth factor receptor beta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro","volume":"40","author":"Fierro","year":"2007","journal-title":"Cell Prolif."},{"key":"10.1016\/j.taap.2011.04.019_bb0040","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1182\/blood-2007-07-104281","article-title":"Long-term imatinib therapy promotes bone formation in CML patients","volume":"111","author":"Fitter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.taap.2011.04.019_bb0045","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1056\/NEJMc062388","article-title":"Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism","volume":"355","author":"Grey","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2011.04.019_bb0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1359\/jbmr.1998.13.4.683","article-title":"Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay","volume":"13","author":"Halleen","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.taap.2011.04.019_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ijc.23903","article-title":"Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals","volume":"124","author":"Hiraga","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2011.04.019_bb0060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/endo.134.3.8119182","article-title":"Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts","volume":"134","author":"Hock","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2011.04.019_bb0065","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.89.20.9637","article-title":"Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts","volume":"89","author":"Hofstetter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.taap.2011.04.019_bb0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S8756-3282(96)00217-7","article-title":"Distribution of platelet-derived growth factor (PDGF). A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone","volume":"19","author":"Horner","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.taap.2011.04.019_bb0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S8756-3282(98)00076-3","article-title":"Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia","volume":"23","author":"Jamsa","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.taap.2011.04.019_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","article-title":"CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells","volume":"7","author":"Jin","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2011.04.019_bb0205","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1210\/jc.2009-2319","article-title":"Tracking of bone mass and density during childhood and adolescence","volume":"95","author":"Kalkwarf","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2011.04.019_bb0090","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1158\/1078-0432.CCR-07-5134","article-title":"Regulation of hematopoietic stem cells by the steel factor\/KIT signaling pathway","volume":"14","author":"Kent","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2011.04.019_bb0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12185-008-0251-8","article-title":"Growth deceleration in a girl treated with imatinib","volume":"89","author":"Kimoto","year":"2009","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.taap.2011.04.019_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/mol.63.2.276","article-title":"Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571","volume":"63","author":"Kumar","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2011.04.019_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.matbio.2005.10.005","article-title":"Cystatin B as an intracellular modulator of bone resorption","volume":"25","author":"Laitala-Leinonen","year":"2006","journal-title":"Matrix Biol."},{"key":"10.1016\/j.taap.2011.04.019_bb0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/73542","article-title":"Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation","volume":"24","author":"Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2011.04.019_bb0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/COC.0b013e31819cccdc","article-title":"Phase I trial of zoledronic acid+imatinib mesylate (Gleevec) in patients with bone metastases","volume":"33","author":"Lipton","year":"2010","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.taap.2011.04.019_bb0120","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1242\/jcs.00376","article-title":"Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation","volume":"116","author":"Liu","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.taap.2011.04.019_bb0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2011.04.019_bb0130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1359\/JBMR.041209","article-title":"Deletion of membrane-bound steel factor results in osteopenia in mice","volume":"20","author":"Lotinun","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.taap.2011.04.019_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(08)61023-5","article-title":"Low bone density and decreased inhibin-B\/FSH ratio in a boy treated with imatinib during puberty","volume":"372","author":"Mariani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2011.04.019_bb0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/tera.1420220306","article-title":"Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S","volume":"22","author":"McLeod","year":"1980","journal-title":"Teratology"},{"key":"10.1016\/j.taap.2011.04.019_bb0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2605.2007.00755.x","article-title":"Inhibition of tyrosine kinases PDGFR and C-Kit by imatinib mesylate interferes with postnatal testicular development in the rat","volume":"30","author":"Nurmio","year":"2007","journal-title":"Int. J. Androl."},{"key":"10.1016\/j.taap.2011.04.019_bb0150","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1359\/jbmr.070719","article-title":"Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms","volume":"22","author":"O'Sullivan","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.taap.2011.04.019_bb0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00223-010-9429-1","article-title":"Imatinib mesylate does not increase bone volume in vivo","volume":"88","author":"O'Sullivan","year":"2011","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.taap.2011.04.019_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/joca.2000.0298","article-title":"Osteoarthritis-like lesions in transgenic mice harboring a small deletion mutation in type II collagen gene","volume":"8","author":"S\u00e4\u00e4m\u00e4nen","year":"2000","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.taap.2011.04.019_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-59745-402-5_21","article-title":"Analysis of arthritic lesions in the Del1 mouse: a model for osteoarthritis","volume":"136","author":"S\u00e4\u00e4m\u00e4nen","year":"2007","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.taap.2011.04.019_bb0170","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.180.4.2045","article-title":"Kit regulates maintenance of quiescent hematopoietic stem cells","volume":"180","author":"Thoren","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2011.04.019_bb0175","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/leu.2009.150","article-title":"Imatinib mesylate causes growth plate closure in vivo","volume":"23","author":"Vandyke","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.taap.2011.04.019_bb0180","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood-2009-08-237404","article-title":"Dysregulation of bone remodeling by imatinib mesylate","volume":"115","author":"Vandyke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.taap.2011.04.019_bb0185","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.taap.2011.04.019_bb0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/scd.2007.0101","article-title":"Murine hematopoietic stem cells and multipotent progenitors express truncated intracellular form of c-kit receptor","volume":"17","author":"Zayas","year":"2008","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.taap.2011.04.019_bb0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/bbrc.1998.9412","article-title":"Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone resorption directly: the role of receptor beta","volume":"251","author":"Zhang","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11001682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11001682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:39:50Z","timestamp":1758573590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X11001682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0041008X11001682"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2011.04.019","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2011.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}